Published in Chest on June 01, 2005
Nosocomial methicillin-resistant Staphylococcus aureus (MRSA) pneumonia: linezolid or vancomycin? - Comparison of pharmacology and clinical efficacy. Eur J Med Res (2010) 0.94
Recommendations for improving the design, conduct, and analysis of clinical trials in hospital-acquired pneumonia and ventilator-associated pneumonia. Clin Infect Dis (2010) 0.83
Comparative effectiveness of linezolid and vancomycin among a national cohort of patients infected with methicillin-resistant Staphylococcus aureus. Antimicrob Agents Chemother (2010) 0.80
Effect of herpes simplex suppression on incidence of HIV among women in Tanzania. N Engl J Med (2008) 7.49
Trends in antimicrobial drug development: implications for the future. Clin Infect Dis (2004) 5.23
Syphilis in pregnancy in Tanzania. I. Impact of maternal syphilis on outcome of pregnancy. J Infect Dis (2002) 3.22
Patient-reported outcomes to support medical product labeling claims: FDA perspective. Value Health (2007) 3.16
Formation of 17-allylamino-demethoxygeldanamycin (17-AAG) hydroquinone by NAD(P)H:quinone oxidoreductase 1: role of 17-AAG hydroquinone in heat shock protein 90 inhibition. Cancer Res (2005) 3.09
Herpes simplex virus type 2 infection increases HIV incidence: a prospective study in rural Tanzania. AIDS (2002) 2.93
Incidence of HIV infection in stable sexual partnerships: a retrospective cohort study of 1802 couples in Mwanza Region, Tanzania. J Acquir Immune Defic Syndr (2002) 2.60
World Health Organization ranking of antimicrobials according to their importance in human medicine: A critical step for developing risk management strategies for the use of antimicrobials in food production animals. Clin Infect Dis (2009) 2.54
Syphilis in pregnancy in Tanzania. II. The effectiveness of antenatal syphilis screening and single-dose benzathine penicillin treatment for the prevention of adverse pregnancy outcomes. J Infect Dis (2002) 2.39
Rapid microfluidic mixing. Anal Chem (2002) 2.18
NAD(P)H:quinone oxidoreductase 1: role as a superoxide scavenger. Mol Pharmacol (2004) 2.18
Randomized controlled safety and efficacy trial of 2 vitamin A supplementation schedules in Tanzanian infants. Am J Clin Nutr (2007) 2.11
Standardizing measurement of chronic obstructive pulmonary disease exacerbations. Reliability and validity of a patient-reported diary. Am J Respir Crit Care Med (2010) 2.09
Correlation between bacteriologic and clinical endpoints in trials of acute otitis media. Pediatr Infect Dis J (2003) 1.98
Association of late-onset Alzheimer's disease with genetic variation in multiple members of the GAPD gene family. Proc Natl Acad Sci U S A (2004) 1.95
Risk factors influencing HIV infection incidence in a rural African population: a nested case-control study. J Infect Dis (2005) 1.88
Voriconazole versus liposomal amphotericin B in patients with neutropenia and persistent fever. N Engl J Med (2002) 1.87
Adverse birth outcomes in United Republic of Tanzania--impact and prevention of maternal risk factors. Bull World Health Organ (2007) 1.78
Fluoroquinolone-resistant Campylobacter species and the withdrawal of fluoroquinolones from use in poultry: a public health success story. Clin Infect Dis (2007) 1.76
Risk factors for herpes simplex virus type 2 and HIV among women at high risk in northwestern Tanzania: preparing for an HSV-2 intervention trial. J Acquir Immune Defic Syndr (2007) 1.69
A comparison of intent-to-treat and per-protocol results in antibiotic non-inferiority trials. Stat Med (2005) 1.67
Diagnosis of lyme disease. Am Fam Physician (2005) 1.56
Update on the management and treatment of hepatitis C virus infection: recommendations from the Department of Veterans Affairs Hepatitis C Resource Center Program and the National Hepatitis C Program Office. Am J Gastroenterol (2012) 1.55
Biomarkers and surrogate endpoints in clinical trials. Stat Med (2012) 1.53
Association of NAD(P)H: quinone oxidoreductase 1 (NQO1) C609T polymorphism with esophageal squamous cell carcinoma in a German Caucasian and a northern Chinese population. Carcinogenesis (2003) 1.43
NAD(P)H:quinone oxidoreductase 1 (NQO1) in the sensitivity and resistance to antitumor quinones. Biochem Pharmacol (2011) 1.41
Intramural radiofrequency ablation: effects of electrode temperature and length. Pacing Clin Electrophysiol (2004) 1.40
Mycobacterium ulcerans ulcers: a proposed surgical management algorithm. Ann Plast Surg (2006) 1.39
Transactional sex amongst young people in rural northern Tanzania: an ethnography of young women's motivations and negotiation. Reprod Health (2010) 1.39
Human papillomavirus vaccination in Tanzanian schoolgirls: cluster-randomized trial comparing 2 vaccine-delivery strategies. J Infect Dis (2012) 1.38
Identification of two gene variants associated with risk of advanced fibrosis in patients with chronic hepatitis C. Gastroenterology (2006) 1.38
Comparison of HIV prevalences in community-based and antenatal clinic surveys in rural Mwanza, Tanzania. AIDS (2002) 1.38
Clinical applications of forced oscillation to assess peripheral airway function. Respir Physiol Neurobiol (2005) 1.34
Issues in noninferiority trials: the evidence in community-acquired pneumonia. Clin Infect Dis (2008) 1.32
A model for community representation and participation in HIV prevention trials among women who engage in transactional sex in Africa. AIDS Care (2008) 1.30
Update of the NAD(P)H:quinone oxidoreductase (NQO) gene family. Hum Genomics (2006) 1.27
A case-control association study of the 12 single-nucleotide polymorphisms implicated in Parkinson disease by a recent genome scan. Am J Hum Genet (2006) 1.26
Interaction of human NAD(P)H:quinone oxidoreductase 1 (NQO1) with the tumor suppressor protein p53 in cells and cell-free systems. J Biol Chem (2003) 1.24
Subcellular localization of NAD(P)H:quinone oxidoreductase 1 in human cancer cells. Cancer Res (2002) 1.21
The benefits of participatory methodologies to develop effective community dialogue in the context of a microbicide trial feasibility study in Mwanza, Tanzania. BMC Public Health (2007) 1.19
Risk factors for HIV incidence in women participating in an HSV suppressive treatment trial in Tanzania. AIDS (2009) 1.14
HIV Care Continuum Applied to the US Department of Veterans Affairs: HIV Virologic Outcomes in an Integrated Health Care System. J Acquir Immune Defic Syndr (2015) 1.13
Factors affecting post-operative complications following skin sparing mastectomy with immediate breast reconstruction. Breast (2010) 1.13
Sexual risk behaviour for women working in recreational venues in Mwanza, Tanzania: considerations for the acceptability and use of vaginal microbicide gels. Cult Health Sex (2009) 1.10
Summer birth and deficit schizophrenia: a pooled analysis from 6 countries. Arch Gen Psychiatry (2004) 1.09
Synthesis and biological evaluation of coumarin-based inhibitors of NAD(P)H: quinone oxidoreductase-1 (NQO1). J Med Chem (2009) 1.09
EHRA/HRS/APHRS expert consensus on ventricular arrhythmias. Heart Rhythm (2014) 1.08
Outcomes in octogenarians undergoing coronary artery bypass grafting. CMAJ (2005) 1.08
The bioreduction of a series of benzoquinone ansamycins by NAD(P)H:quinone oxidoreductase 1 to more potent heat shock protein 90 inhibitors, the hydroquinone ansamycins. Mol Pharmacol (2006) 1.07
Using the rate of bacterial clearance determined by real-time polymerase chain reaction to evaluate antibiotic effectiveness in Acinetobacter baumannii bacteremia. Crit Care Med (2013) 1.07
Treatment of veterans with hepatitis C in the United States Department of Veterans Affairs. J Hepatol (2013) 1.06
Anti-infective research and development--problems, challenges, and solutions. Lancet Infect Dis (2007) 1.05
Sample size and the ethics of non-inferiority trials. Lancet (2005) 1.05
Diet-induced obesity and hepatic gene expression alterations in C57BL/6J and ICAM-1-deficient mice. Am J Physiol Endocrinol Metab (2002) 1.04
Exercise-induced pulmonary hypertension associated with systemic sclerosis: four distinct entities. Arthritis Rheum (2010) 1.04
The need to promote behaviour change at the cultural level: one factor explaining the limited impact of the MEMA kwa Vijana adolescent sexual health intervention in rural Tanzania. A process evaluation. BMC Public Health (2012) 1.03
A potential role for cyclized quinones derived from dopamine, DOPA, and 3,4-dihydroxyphenylacetic acid in proteasomal inhibition. Mol Pharmacol (2006) 1.03
Evidence that common variation in NEDD9 is associated with susceptibility to late-onset Alzheimer's and Parkinson's disease. Hum Mol Genet (2007) 1.03
Multiple variants in toll-like receptor 4 gene modulate risk of liver fibrosis in Caucasians with chronic hepatitis C infection. J Hepatol (2009) 1.02
C4d staining of pulmonary allograft biopsies: an immunoperoxidase study. J Heart Lung Transplant (2005) 1.01
NQO1 expression in pancreatic cancer and its potential use as a biomarker. Appl Immunohistochem Mol Morphol (2008) 1.00
Uptake of voluntary counselling and testing among young people participating in an HIV prevention trial: comparison of opt-out and opt-in strategies. PLoS One (2012) 1.00
Antibacterial R&D incentives. Nat Rev Drug Discov (2011) 1.00
Neither replication nor simulation supports a role for the axon guidance pathway in the genetics of Parkinson's disease. PLoS One (2008) 0.99
Enzymatic reduction and glutathione conjugation of benzoquinone ansamycin heat shock protein 90 inhibitors: relevance for toxicity and mechanism of action. Drug Metab Dispos (2008) 0.99
Interaction of the molecular chaperone Hsp70 with human NAD(P)H:quinone oxidoreductase 1. J Biol Chem (2002) 0.98
Nrf2 controls bone marrow stromal cell susceptibility to oxidative and electrophilic stress. Free Radic Biol Med (2006) 0.98
Linezolid and vancomycin for methicillin-resistant Staphylococcus aureus nosocomial pneumonia: the subtleties of subgroup analyses. Chest (2004) 0.97
Development of indolequinone mechanism-based inhibitors of NAD(P)H:quinone oxidoreductase 1 (NQO1): NQO1 inhibition and growth inhibitory activity in human pancreatic MIA PaCa-2 cancer cells. Biochemistry (2007) 0.97
Unusual dislocation of the elbow in a child--review of literature. J Trauma (2008) 0.97
Community-acquired pneumonia: symptoms and burden of illness at diagnosis among US adults aged 50 years and older. Patient (2013) 0.96
Approval and withdrawal of new antibiotics and other antiinfectives in the U.S., 1980-2009. J Law Med Ethics (2013) 0.95
Synthesis of 19-substituted geldanamycins with altered conformations and their binding to heat shock protein Hsp90. Nat Chem (2013) 0.94
The United States Food and Drug Administration and noninferiority margins in clinical trials of antimicrobial agents. Clin Infect Dis (2002) 0.94
The highly expressed and inducible endogenous NAD(P)H:quinone oxidoreductase 1 in cardiovascular cells acts as a potential superoxide scavenger. Cardiovasc Toxicol (2007) 0.94
Antitumor indolequinones induced apoptosis in human pancreatic cancer cells via inhibition of thioredoxin reductase and activation of redox signaling. Mol Pharmacol (2011) 0.93
Duodenal infusion of feces for recurrent Clostridium difficile. N Engl J Med (2013) 0.93
Association between NAD(P)H: quinone oxidoreductase 1 (NQ01) inactivating C609T polymorphism and adenocarcinoma of the upper gastrointestinal tract. Int J Cancer (2003) 0.92
Are women who work in bars, guesthouses and similar facilities a suitable study population for vaginal microbicide trials in Africa? PLoS One (2010) 0.92
A ride in the time machine: information management capabilities health departments will need. Am J Public Health (2014) 0.92
The role of non-viraemic transmission on the persistence and dynamics of a tick borne virus--Louping ill in red grouse ( Lagopus lagopus scoticus) and mountain hares ( Lepus timidus). J Math Biol (2003) 0.92
5-Methoxy-1,2-dimethyl-3-[(4-nitrophenoxy)methyl]indole-4,7-dione, a mechanism-based inhibitor of NAD(P)H:quinone oxidoreductase 1, exhibits activity against human pancreatic cancer in vitro and in vivo. Mol Cancer Ther (2006) 0.92
Potent activity of indolequinones against human pancreatic cancer: identification of thioredoxin reductase as a potential target. Mol Pharmacol (2009) 0.91
A comparative study of proteasomal inhibition and apoptosis induced in N27 mesencephalic cells by dopamine and MG132. J Neurochem (2007) 0.91
Expanded HIV testing in the US Department of Veterans Affairs, 2009-2011. Am J Public Health (2013) 0.90
Beyond intuition: patient fever symptom experience. J Pain Symptom Manage (2013) 0.90
Reassessing the design, conduct, and analysis of clinical trials of therapy for community-acquired pneumonia. Clin Infect Dis (2008) 0.90
Enzyme specific activation of benzoquinone ansamycin prodrugs using HuCC49DeltaCH2-beta-galactosidase conjugates. J Med Chem (2006) 0.90
Immediate microvascular breast reconstruction after neoadjuvant chemotherapy: complication rates and effect on start of adjuvant treatment. Ann Surg Oncol (2010) 0.90
EHRA/HRS/APHRS expert consensus on ventricular arrhythmias. Europace (2014) 0.90
Perioperative morbidity and mortality following bilateral total hip arthroplasty. J Arthroplasty (2013) 0.89
Rationales, obstacles and strategies for local outcome monitoring systems in substance abuse treatment settings. J Subst Abuse Treat (2003) 0.89
Effects of simultaneous insertion of 66 plunge needle electrodes on myocardial activation, function, and structure. Pacing Clin Electrophysiol (2003) 0.89
Role for NAD(P)H:quinone oxidoreductase 1 and manganese-dependent superoxide dismutase in 17-(allylamino)-17-demethoxygeldanamycin-induced heat shock protein 90 inhibition in pancreatic cancer cells. J Pharmacol Exp Ther (2010) 0.89
Dissecting the role of multiple reductases in bioactivation and cytotoxicity of the antitumor agent 2,5-diaziridinyl-3-(hydroxymethyl)-6-methyl-1,4-benzoquinone (RH1). Mol Pharmacol (2008) 0.88
Need to improve routine HIV testing of U.S. Veterans in care: results of an Internet survey. J Community Health (2010) 0.88
Lung transplantation and coronary artery disease. Ann Thorac Surg (2011) 0.87